Contrarian7 : Agreed. Haters gonna hate, they come to moomoo to boast about shorting when moomoo don't even have the option to short for most of these penny stocks, same at webull lots of short sellers there although webull also don't have short inventory for most penny stocks. Some stocks have millions in short volume eventually these millions of shorted stocks will need to be converted into buying volume but short sellers are not coordinated there will be some with large short positions who wants to instantly lock profits with market order thereby squeezing the rest of retail short sellers.

Contrarian7 : exactly, one gets phase 2 data on a rare disease and it explodes, whereas another gets FDA approval for common kidney disease (drug easily worth more than $1B), plus ARDX has sufficient cash flow with $50M capital injection till 2025. ARDX has earnings coming up 31 Oct should easily clear $4.50 afterwards.